4,895
Views
12
CrossRef citations to date
0
Altmetric
Research Articles

Magnesium ascorbyl phosphate vesicular carriers for topical delivery; preparation, in-vitro and ex-vivo evaluation, factorial optimization and clinical assessment in melasma patients

, , , , & ORCID Icon
Pages 534-547 | Received 09 Dec 2021, Accepted 25 Jan 2022, Published online: 14 Feb 2022

References

  • Abdelbary G, El-Gendy N. (2008). Niosome-encapsulated gentamicin for ophthalmic controlled delivery. AAPS PharmSciTech 9:740–7.
  • Abdelkader H, Farghaly U, Moharram H. (2014). Effects of surfactant type and cholesterol level on niosomes physical properties and in vivo ocular performance using timolol maleate as a model drug. J Pharm Investig 44:329–37.
  • Abdulbaqi IM, Darwis Y, Khan NA, et al. (2016). Ethosomal nanocarriers: the impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials. Int J Nanomed 11:2279–304.
  • Aboul-Einien MH, Kandil SM, Abdou EM, et al. (2020). Ascorbic acid derivative-loaded modified aspasomes: formulation, in vitro, ex vivo and clinical evaluation for melasma treatment. J Liposome Res 30:54–67.
  • Aggarwal N, Goindi S. (2013). Dermatopharmacokinetic and pharmacodynamic evaluation of ethosomes of griseofulvin designed for dermal delivery. J Nanopart Res 15:1983.
  • Al-Mahallawi AM, Abdelbary AA, Aburahma MH. (2015). Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam. Int J Pharm 485:329–40.
  • Al-Mahallawi AM, Khowessah OM, Shoukri RA. (2014). Nano-transfersomal ciprofloxacin loaded vesicles for non-invasive trans-tympanic ototopical delivery: in-vitro optimization, ex-vivo permeation studies, and in-vivo assessment . Int J Pharm 472:304–14.
  • Al-niaimi F, Chiang NZ. (2017). Topical vitamin C and the skin: mechanisms of action and clinical applications. J Clin Aesthetic Dermatol 10:14–7.
  • Apridamayanti P, Listiyana N, Desnita R. (2016). Formulation vitamin C using niosomes system span 80 in gel for increase stability and penetration in vitro. Int J Pharm Tech Res 9:81–8.
  • Barupal AK, Gupta V, Ramteke S. (2010). Preparation and characterization of ethosomes for topical delivery of aceclofenac. Indian J Pharm Sci 72:582–6.
  • Basha M, Abd El-Alim SH, Shamma RN, Awad GE. (2013). Design and optimization of surfactant-based nanovesicles for ocular delivery of Clotrimazole. J Liposome Res 23:203–10.
  • Basiri L, Rajabzadeh G, Bostan A. (2017). Physicochemical properties and release behavior of Span 60/Tween 60 niosomes as vehicle for α-Tocopherol delivery. LWT 84:471–8.
  • Cestari TF, Dantas LP, Boza JC. (2014). Acquired hyperpigmentations. An Bras Dermatol 89:11–25.
  • Chen M, Liu X, Fahr A. (2011). Skin penetration and deposition of carboxyfluorescein and temoporfin from different lipid vesicular systems: in vitro study with finite and infinite dosage application. Int J Pharm 408:223–34.
  • Dave V, Kumar D, Lewis S, Paliwal S. (2010). Ethosome for enhanced transdermal drug delivery of aceclofenac. Int J Drug Delivery 2:81–92.
  • Dina F, Eman MKY, Ghareb MS. (2020). Liposomal and ethosomal gels for the topical delivery of anthralin: preparation, comparative evaluation and clinical assessment in psoriatic patients. Pharmaceutics 12:446.
  • Dua J, Rana A, Bhandari A. (2012). Liposome: Methods of preparation and applications. Int J Pharm Stud Res 3:14–20.
  • Dubey V, Mishra D, Dutta T, et al. (2007). Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J Control Release 123:148–54.
  • Faisal W, Soliman GM, Hamdan AM. (2018). Enhanced skin deposition and delivery of voriconazole using ethosomal preparations. J Liposome Res 28:14–21.
  • Godin B, Touitou E. (2005). Erythromycin ethosomal systems: physicochemical characterization and enhanced antibacterial activity. Curr Drug Deliv 2:269–75.
  • Hallan SS, Sguizzato M, Mariani P, et al. (2020). Design and characterization of ethosomes for transdermal delivery of caffeic acid. Pharmaceutics 12:740.
  • Hongdan M, Dongyan G, Yu F, et al. (2018). Paeonol-loaded ethosomes as transdermal delivery carriers: design, preparation and evaluation. Molecules 23:1756.
  • Imam SS, Ahad A, Aqil M, et al. (2017). Formulation by design based risperidone nano soft lipid vesicle as a new strategy for enhanced transdermal drug delivery: In-vitro characterization, and in-vivo appraisal. Mater Sci Eng C Mater Biol Appl 75:1198–205.
  • Imam SS, Aqil M, Akhtar M, et al. (2015). Formulation by design-based proniosome for accentuated transdermal delivery of risperidone: in vitro characterization and in vivo pharmacokinetic study. Drug Deliv 22:1059–70.
  • Jain S, Patel N, Madan P, Lin S. (2015). Quality by design approach for formulation, evaluation and statistical optimization of diclofenac-loaded ethosomes via transdermal route. Pharm Dev Technol 20:473–89.
  • Jain S, Tiwary AK, Sapra B, Jain NK. (2007). Formulation and evaluation of ethosomes for transdermal delivery of lamivudine. AAPS PharmSciTech 8:E111.
  • Kang WH, Yoon KH, Lee ES, et al. (2002). Melasma: histopathological characteristics in 56 Korean patients. Br J Dermatol 146:228–37.
  • Karsono L, Harahap U. (2016). Comparison of Vitamin C (magnesium ascorbyl phosphate) formulation in nanoemulsion spray and cream as anti-aging. Int J PharmTech Res 9:399–407.
  • Kazi KM, Mandal AS, Biswas N, et al. (2010). Niosome: a future of targeted drug delivery systems. J Adv Pharm Technol Res 1:374–80.
  • Kelchen MN, Brogden NK. (2018). In vitro skin retention and drug permeation through intact and microneedle pretreated skin after application of propranolol loaded microemulsions. Pharm Res 35:228.
  • Khan DH, Bashir S, Correia A, et al. (2019). Utilization of green formulation technique and efficacy estimation on cell line studies for dual anticancer drug therapy with niosomes. Int J Pharm 572:118764.
  • Kim B, Cho H, Moon SH, et al. (2020). Transdermal delivery systems in cosmetics. Biomed Dermatol 4:10.
  • Kumar S, Bhargava D, Thakkar A, Arora S. (2013). Drug carrier systems for solubility enhancement of BCS class II drugs: a critical review. Crit Rev Ther Drug Carrier Syst 30:217–56.
  • Liu X, Liu H, Liu J, et al. (2011). Preparation of a ligustrazine ethosome patch and its evaluation in vitro and in vivo. Int J Nanomedicine 6:241–7.
  • Lykkesfeldt J, Tveden-Nyborg P. (2019). Tveden-Nyborg P. The pharmacokinetics of vitamin C. Nutrients 11:2412.
  • Madhavi N, Sudhakar B, Reddy KVNS, Ratna VJ. (2019). Design by optimization and comparative evaluation of vesicular gels of etodolac for transdermal delivery. Drug Dev Ind Pharm 45:611–28.
  • Marwa A, Omaima S, Hanaa E, Mohammed A. (2013). Preparation and in-vitro evaluation of diclofenac sodium niosomal formulations. Int J Pharm Sci Res 4:1757–65.
  • Menon A, Eram H, Prashanth R, et al. (2020). A split face comparative study of safety and efficacy of microneedling with tranexamic acid versus microneedling with vitamin C in the treatment of melasma. Indian Dermatol Online J 11:41–5.
  • Muller RH, Jacobs C, Kayser O. (2001). Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Adv Drug Deliv Rev 47:3–19.
  • Murtaza F, Bangash A, Khushdil A, Noor SM. (2016). Efficacy of trichloro-acetic acid peel alone versus combined topical magnesium ascorbyl phosphate for epidermal melasma. J College Phys Surg Pakistan 26:557–61.
  • Paolino D, Lucania G, Mardente D, et al. (2005). Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J Control Release 106:99–110.
  • Pawar HA, Attarde VB, Subhash GP. (2016). Optimization of bifonazole-loaded nisomal formulation using plackett-burman design and 23 factorial design. Open Pharmaceutical Sci J 3:31–48.
  • Ravalika V, Sailaja AK. (2017). Formulation and evaluation of etoricoxib niosomes by thin film hydration technique and ether injection method. Nano Biomed Eng 9:242–8.
  • Rehman K, Zulfakar MH. (2014). Recent advances in gel technologies for topical and transdermal drug delivery. Drug Dev Ind Pharm 40:433–40.
  • Salama HA, Mahmoud AA, Kamel AO, et al. (2012). Phospholipid based colloidal poloxamer-nanocubic vesicles for brain targeting via the nasal route. Colloids Surf B Biointerfaces 100:146–54.
  • Sankhyan A, Pawar PK. (2013). Metformin loaded non-ionic surfactant vesicles: optimization of formulation, effect of process variables and characterization. Daru 21:7–8.
  • Smaoui S, Hajer B, Adel K. (2013). Application of l-ascorbic acid and its derivatives (sodium ascorbyl phosphate and magnesium ascorbyl phosphate) in topical cosmetic formulations: stability studies. J Chem Soc Pakistan 35:1096–102.
  • Smith WP. (1999). The effects of topical l(+) lactic Acid and ascorbic Acid on skin whitening. Int J Cosmet Sci 21:33–40.
  • Stamford NP. (2012). Stability, transdermal penetration, and cutaneous effects of ascorbic acid and its derivatives. J Cosmet Dermatol 11:310–7.
  • Sujatha S, Sowmya GM, Chaitanya VS, et al. (2016). Preparation, characterization and evaluation of finasteride ethosomes. Int J Drug Delivery 8:01–11.
  • Talakoub L, Neuhaus IM, Yu SS. Cosmeceuticals. In: Alam M, Gladstone H.B., Tung R.C., editors. Cosmetic dermatology. Vol. 1. Requisites in Dermatology. 1st ed. Gurgaon: Saunders Elsevier, 2009. pp. 13–4.
  • Telang SP. (2013). Vitamin C in dermatology. Indian Dermatol Online J 4:143–6.
  • Tiwari R, Tiwari G, Wal P, et al. (2018). Development, characterization and transdermal delivery of dapsone and an antibiotic entrapped in ethanolic liposomal gel for the treatment of lapromatous leprosy. TONMJ 5:1–15.
  • Touitou E. (2002). Drug delivery across the skin. Expert Opin Biol Ther 2:723–33.
  • Touitou E, Dayan N, Bergelson L, et al. (2000). Ethosomes – novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 65:403–18.
  • Tunyaluk L, Boonme P, Khongkow P, Amnuaikit T. (2017). Ethosomes of phenylethyl resorcinol as vesicular delivery system for skin lightening applications. Biomed Res Int 2017:8310979–12.
  • Verma DD, Verma S, Blume G, Fahr A. (2003). Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm 258:141–51.
  • Vyshnavi V, Indira S, Srinivas P. (2015). Formulation and evaluation of nasal niosomal in situ gels of loratadine. Int J Pharm Sci Drug Res 7:13–21.
  • Wang PC, Huang YL, Hou SS, et al. (2013). Lauroyl/palmitoyl glycol chitosan gels enhance skin delivery of magnesium ascorbyl phosphate. J Cosmet Sci 64:273–86.
  • Yeo LK, Chaw CS, Elkordy AA. (2019). The effects of hydration parameters and co-surfactants on methylene blue-loaded niosomes prepared by the thin film hydration method. Pharmaceuticals 12:46.
  • Zhaowu Z, Xiaoli W, Yangde Z, Nianfeng L. (2009). Preparation of matrine ethosome, its percutaneous permeation in vitro and anti-inflammatory activity in vivo in rats. J Liposome Res 19:155–62.
  • Zhou Y, Wei H, Zhang Q, Wu A. (2010). Synergistic penetration of ethosomes and lipophilic prodrug on the transdermal delivery of acyclovir. Arch Pharm Res 33:567–74.